About
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antiΒhypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap6,864 Cr
P/E34.50
Div Yield0.12 %
Book ValueβΉ149.00
52w HighβΉ1,086.00
52w LowβΉ546.00
Face ValueβΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 190.00 | 277.00 | 206.00 | 200.00 | 145.00 | 184.00 | 186.00 | 166.00 | 161.00 | 158.00 | 140.00 | 140.00 | 132.00 |
| Expenses | 142.00 | 179.00 | 134.00 | 127.00 | 93.00 | 117.00 | 120.00 | 101.00 | 98.00 | 103.00 | 99.00 | 108.00 | 88.00 |
| Operating Profit | 47.00 | 98.00 | 72.00 | 73.00 | 52.00 | 68.00 | 66.00 | 65.00 | 63.00 | 56.00 | 41.00 | 32.00 | 44.00 |
| OPM % | 25.00 | 35.00 | 35.00 | 36.00 | 36.00 | 37.00 | 36.00 | 39.00 | 39.00 | 35.00 | 30.00 | 23.00 | 34.00 |
| Other Income | 3.00 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 2.00 | 3.00 | 2.00 | 2.00 | 3.00 | 2.00 | 3.00 |
| Depreciation | 9.00 | 8.00 | 7.00 | 7.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 1.00 |
| Profit before tax | 41.00 | 92.00 | 67.00 | 68.00 | 47.00 | 64.00 | 63.00 | 62.00 | 60.00 | 53.00 | 40.00 | 30.00 | 43.00 |
| Tax % | 41.00 | 19.00 | 26.00 | 26.00 | 27.00 | 21.00 | 25.00 | 26.00 | 25.00 | 31.00 | 26.00 | 20.00 | 33.00 |
| Net Profit | 24.00 | 74.00 | 50.00 | 50.00 | 35.00 | 50.00 | 47.00 | 46.00 | 45.00 | 37.00 | 30.00 | 24.00 | 29.00 |
| EPS in Rs | 2.99 | 9.22 | 6.17 | 6.27 | 4.32 | 6.26 | 5.81 | 5.73 | 5.55 | 4.59 | 3.70 | 2.97 | 3.54 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 828.00 | 696.00 | 570.00 | 461.00 | 530.00 | 391.00 | 312.00 | 278.00 | 213.00 | 184.00 |
| Expenses | 534.00 | 436.00 | 394.00 | 332.00 | 316.00 | 218.00 | 213.00 | 213.00 | 191.00 | 166.00 |
| Operating Profit | 294.00 | 261.00 | 176.00 | 129.00 | 214.00 | 173.00 | 98.00 | 65.00 | 22.00 | 17.00 |
| OPM % | 36.00 | 37.00 | 31.00 | 28.00 | 40.00 | 44.00 | 32.00 | 23.00 | 10.00 | 9.00 |
| Other Income | 11.00 | 10.00 | 11.00 | 9.00 | 8.00 | 5.00 | 11.00 | 8.00 | 9.00 | 7.00 |
| Interest | 2.00 | 2.00 | 5.00 | 3.00 | 4.00 | 4.00 | 7.00 | 10.00 | 11.00 | 12.00 |
| Depreciation | 28.00 | 20.00 | 16.00 | 12.00 | 10.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 |
| Profit before tax | 275.00 | 248.00 | 166.00 | 123.00 | 207.00 | 167.00 | 96.00 | 57.00 | 14.00 | 8.00 |
| Tax % | 24.00 | 24.00 | 28.00 | 27.00 | 27.00 | 26.00 | 24.00 | 31.00 | 40.00 | 30.00 |
| Net Profit | 209.00 | 188.00 | 119.00 | 90.00 | 152.00 | 124.00 | 73.00 | 39.00 | 9.00 | 6.00 |
| EPS in Rs | 25.98 | 23.35 | 14.80 | 11.17 | 18.86 | 16.89 | 50.11 | 26.93 | 5.96 | 3.87 |
| Dividend Payout % | 4.00 | 4.00 | 5.00 | 5.00 | 3.00 | 3.00 | 20.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16.00 | 16.00 | 16.00 | 16.00 | 16.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
| Reserves | 1,182.00 | 981.00 | 799.00 | 683.00 | 600.00 | 254.00 | 134.00 | 79.00 | 40.00 | 31.00 |
| Borrowings | 5.00 | 5.00 | 5.00 | 22.00 | 27.00 | 72.00 | 82.00 | 90.00 | 130.00 | 140.00 |
| Other Liabilities | 154.00 | 110.00 | 101.00 | 98.00 | 92.00 | 105.00 | 105.00 | 69.00 | 60.00 | 55.00 |
| Total Liabilities | 1,357.00 | 1,112.00 | 921.00 | 820.00 | 735.00 | 445.00 | 336.00 | 253.00 | 245.00 | 241.00 |
| Fixed Assets | 689.00 | 453.00 | 310.00 | 262.00 | 190.00 | 100.00 | 99.00 | 85.00 | 91.00 | 89.00 |
| CWIP | 36.00 | 148.00 | 149.00 | 68.00 | 43.00 | 79.00 | 40.00 | 35.00 | 34.00 | 36.00 |
| Investments | 99.00 | 63.00 | 64.00 | 25.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 534.00 | 448.00 | 399.00 | 466.00 | 502.00 | 267.00 | 197.00 | 133.00 | 120.00 | 117.00 |
| Total Assets | 1,357.00 | 1,112.00 | 921.00 | 820.00 | 735.00 | 445.00 | 336.00 | 253.00 | 245.00 | 241.00 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 165.00 | 113.00 | 64.00 | 49.00 | 76.00 | 117.00 | 49.00 | 28.00 | 27.00 |
| Cash from Investing Activity | -152.00 | -174.00 | -124.00 | -60.00 | -47.00 | -25.00 | 5.00 | -5.00 | -27.00 |
| Cash from Financing Activity | -8.00 | -22.00 | -10.00 | 150.00 | -15.00 | -29.00 | -50.00 | -20.00 | -2.00 |
| Net Cash Flow | 4.00 | -83.00 | -70.00 | 139.00 | 15.00 | 62.00 | 4.00 | 3.00 | -2.00 |
| Free Cash Flow | 2.00 | -32.00 | -44.00 | -11.00 | 29.00 | 92.00 | 54.00 | 23.00 | 0.00 |
| CFO/OP % | 86.00 | 86.00 | 73.00 | 51.00 | 61.00 | 146.00 | 97.00 | 141.00 | 158.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 97.00 | 70.00 | 71.00 | 67.00 | 79.00 | 69.00 | 60.00 | 79.00 | 92.00 | 99.00 |
| Inventory Days | 229.00 | 205.00 | 140.00 | 234.00 | 172.00 | 206.00 | 130.00 | 77.00 | 85.00 | 113.00 |
| Days Payable | 159.00 | 129.00 | 98.00 | 130.00 | 91.00 | 145.00 | 130.00 | 110.00 | 112.00 | 121.00 |
| Cash Conversion Cycle | 167.00 | 146.00 | 114.00 | 171.00 | 160.00 | 130.00 | 61.00 | 45.00 | 64.00 | 91.00 |
| Working Capital Days | 147.00 | 144.00 | 157.00 | 168.00 | 117.00 | 28.00 | -40.00 | -5.00 | -50.00 | -69.00 |
| ROCE % | 25.00 | 27.00 | 22.00 | 19.00 | 43.00 | 60.00 | 50.00 | 37.00 | 14.00 | β |
Corporate Actions
4 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Dividend | 04 Sep 2025 | 05 Sep 2025 | β | 1.00 | |
| Dividend | 20 Sep 2024 | β | β | 0.80 | |
| Dividend | 15 Sep 2023 | β | β | 0.60 | |
| Dividend | 01 Sep 2022 | β | β | 0.60 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results β Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update6 Mar from icra
-
Rating update30 Dec 2025 from fitch
-
Rating update6 Feb 2025 from icra
-
Rating update10 Nov 2023 from icra
-
Rating update26 Sep 2022 from icra
-
Rating update26 Jul 2021 from icra